Tsukasa Seya - Publications, H-index & Citations

Tsukasa Seya

Hokkaido University

82H指数

461论文数

2.5W被引数

收录论文 149

发表时间

CD46 regulates hepatitis B virus entry by modulating cell-surface NTCP levels through cis-interaction CD46通过cis相互作用调节细胞表面NTCP水平来调控乙型肝炎病毒进入

Journal of Molecular Cell Biology

IF5.9

2025-12-23

OAAI

Kei Miyakawa; Yusuke Nakai; Taichi Kameya; Hironori Nishitsuji; Koichi Watashi; Makoto Takeda; Tsukasa Seya; Kunitada Shimotohno; Yayoi Kimura; Akihide Ryo; null

ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction

JOURNAL OF VIROLOGY

IF3.8

2025-04-01

OAAI

Kawakita, Tomomi; Sekiya, Toshiki; Kameda, Yayoi; Nomura, Naoki; Ohno, Marumi; Handabile, Chimuka; Yamaya, Akari; Fukuhara, Hideo; Anraku, Yuki; Kita, Shunsuke; Toba, Shinsuke; Tsukamoto, Hirotake; Sawa, Tomohiro; Oshiumi, Hiroyuki; Itoh, Yasushi; Maenaka, Katsumi; Sato, Akihiko; Sawa, Hirofumi; Suzuki, Yasuhiko; Brown, Lorena E.; Jackson, David C.; Kida, Hiroshi; Matsumoto, Misako; Seya, Tsukasa; Shingai, Masashi

Poly(I:C) signaling induces robust CXCL10 production and apoptosis in human esophageal squamous cell carcinoma cells

HUMAN CELL

IF3.1

2025-03-03

OAAI

Sato, Yusuke; Yamaya, Akari; Sonoda, Kento; Wakita, Akiyuki; Nagaki, Yushi; Sasamori, Ryohei; Sasaki, Yoshihiro; Yoneya, Takatoshi; Nozaki, Shu; Takahashi, Tsukasa; Matsumoto, Misako; Seya, Tsukasa; Imai, Kazuhiro

Th1 adjuvant ARNAX, in combination with radiation therapy, enhances tumor regression in mouse tumor-implant models

IMMUNOLOGY LETTERS

IF2.8

2025-02-01

OAAI

Miyazaki, Aya; Yoshida, Sumito; Takeda, Yohei; Tomaru, Utano; Matsumoto, Misako; Seya, Tsukasa

Two Modes of Th1 Polarization Induced by Dendritic-Cell-Priming Adjuvant in Vaccination

CELLS

IF5.2

2023-05-29

OAAI

Seya, Tsukasa; Shingai, Masashi; Kawakita, Tomomi; Matsumoto, Misako

Disruption of mouse CD46 causes an accelerated spontaneous acrosome reaction in sperm

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-27

128

OAAI

Inoue, N; Ikawa, M; Nakanishi, T; Matsumoto, M; Nomura, M; Seya, T; Okabe, M

DDX60, a DEXD/H Box Helicase, Is a Novel Antiviral Factor Promoting RIG-I-Like Receptor-Mediated Signaling

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-20

254

OAAI

Miyashita, Moeko; Oshiumi, Hiroyuki; Matsumoto, Misako; Seya, Tsukasa

Innate-Acquired Linkage in Immunotherapy

CELLS

IF5.2

2023-01-19

OAAI

Seya, Tsukasa

Toward Establishing an Ideal Adjuvant for Non-Inflammatory Immune Enhancement

CELLS

IF5.2

2022-12-11

OAAI

Seya, Tsukasa; Tatematsu, Megumi; Matsumoto, Misako

Targeting Toll-like receptor 3 in dendritic cells for cancer immunotherapy

EXPERT OPINION ON BIOLOGICAL THERAPY

IF4

2020-04-07

PREAI

Matsumoto, Misako; Takeda, Yohei; Seya, Tsukasa

Cytoplasmic dsRNA induces the expression of OCT3/4 and NANOG mRNAs in differentiated human cells

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2019-12-01

OAAI

Wang, Guanming; Kouwaki, Takahisa; Mugikura, Kazuki; Okamoto, Masaaki; Takaki, Hiromi; Funami, Kenji; Seya, Tsukasa; Oshiumi, Hiroyuki

A Toll-like receptor 3 (TLR3) agonist ARNAX for therapeutic immunotherapy

ADVANCED DRUG DELIVERY REVIEWS

IF17.6

2019-07-01

PREAI

Seya, Tsukasa; Takeda, Yohei; Matsumoto, Misako

Anti-oxidative Amino Acid L-ergothioneine Modulates the Tumor Microenvironment to Facilitate Adjuvant Vaccine Immunotherapy

FRONTIERS IN IMMUNOLOGY

IF5.9

2019-04-04

OAAI

Yoshida, Sumito; Shime, Hiroaki; Matsumoto, Misako; Kasahara, Masanori; Seya, Tsukasa

Alternative pathway activation due to low level of complement factor H in primary antiphospholipid syndrome

THROMBOSIS RESEARCH

IF3.4

2018-04-01

PREAI

Nakamura, Hiroyuki; Oku, Kenji; Ogata, Yusuke; Ohmura, Kazumasa; Yoshida, Yoko; Kitano, Etsuko; Fujieda, Yuichiro; Kato, Masaru; Bohgaki, Toshiyuki; Amengual, Olga; Yasuda, Shinsuke; Fujimura, Yoshihiro; Seya, Tsukasa; Atsumi, Tatsuya

Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide 发酵支原体脂肽诱导的I型干扰素非依赖性树突状细胞启动和抗肿瘤T细胞活化

FRONTIERS IN IMMUNOLOGY

IF5.9

2018-03-14

OAAI

Takeda, Yohei; Azuma, Masahiro; Funami, Kenji; Shime, Hiroaki; Matsumoto, Misako; Seya, Tsukasa

Toll-like receptor 3 in nasal CD103+ dendritic cells is involved in immunoglobulin A production

MUCOSAL IMMUNOLOGY

IF7.6

2018-01-01

OAAI

Takaki, H.; Kure, S.; Oshiumi, H.; Sakoda, Y.; Suzuki, T.; Ainai, A.; Hasegawa, H.; Matsumoto, M.; Seya, T.

Adjuvant immunotherapy for cancer: both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy

PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

IF4.6

2018-01-01

OAAI

Seya, Tsukasa; Takeda, Yohei; Takashima, Ken; Yoshida, Sumit; Azuma, Masahiro; Matsumoto, Misako

Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy 树突状细胞中的Toll样受体3信号有益于癌症免疫治疗

FRONTIERS IN IMMUNOLOGY

IF5.9

2017-12-21

OAAI

Matsumoto, Misako; Takeda, Yohei; Tatematsu, Megumi; Seya, Tsukasa

The TLR3/TICAM-1 signal constitutively controls spontaneous polyposis through suppression of c-Myc in ApcMin/+ mice TLR3/TICAM-1信号通过抑制ApcMin/小鼠中的c-myc来组成性控制自发性息肉病

JOURNAL OF BIOMEDICAL SCIENCE

IF12.1

2017-10-17

OAAI

Ono, Junya; Shime, Hiroaki; Takaki, Hiromi; Takashima, Ken; Funami, Kenji; Yoshida, Sumito; Takeda, Yohei; Matsumoto, Misako; Kasahara, Masanori; Seya, Tsukasa

Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells Toll样受体2配体和干扰素-γ 通过增强单核细胞髓源性抑制细胞的免疫抑制活性来抑制抗肿瘤T细胞反应

ONCOIMMUNOLOGY

IF6.3

2017-09-21

OAAI

Shime, Hiroaki; Maruyama, Akira; Yoshida, Sumito; Takeda, Yohei; Matsumoto, Misako; Seya, Tsukasa

研究方向